Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia

Hung Yuan Li, Jung Nan Wei, Mao Shin Lin, David J. Smith, Jani Vainio, Cheng Hsin Lin, Fu Tien Chiang, Shyang Rong Shih, Ching Huei Huang, Mei Yu Wu, Yenh Chen Hsein, Lee Ming Chuang

研究成果: 雜誌貢獻文章同行評審

46 引文 斯高帕斯(Scopus)

摘要

Background: The relationship between serum vascular adhesion protein-1 (VAP-1) and plasma glucose in normal and drug-naïve type 2 diabetes subjects is unclear. We examined if serum VAP-1 changed acutely to oral glucose loading and analyzed the relationship between serum VAP-1, fasting plasma glucose (FPG), hemoglobin A1c, and type 2 diabetes. Methods: Adults without history of diabetes were included. Subjects taking anti-diabetic drugs were excluded. Serum VAP-1 was analyzed by time-resolved immunofluorometric assay. Results: We recruited 333 subjects (186 females and 147 males), aged 56.1 ± 11.6 y. After glucose challenge, serum VAP-1 rose significantly at 30 min (p <0.0001) and lasted until 2 h (p <0.0001). The change of serum VAP-1 between fasting and 30-min postload correlated inversely to the change of plasma insulin (r = - 0.21, p = 0.049). Fasting serum VAP-1 was associated with FPG in those with FPG ≥ 5.55 mmol/l (p = 0.025) but not in those with FPG <5.55 mmol/l (p = NS). Fasting serum VAP-1 were higher in diabetic subjects (p = 0.04) and correlated positively to hemoglobin A1c (r = 0.18, p = 0.002) after adjusting for age, gender, and waist circumference. Conclusions: Serum VAP-1 is increased in both acute and chronic hyperglycemia. Whether serum VAP-1 is a good biomarker for hyperglycemia-associated complications merits further investigation.

原文英語
頁(從 - 到)149-153
頁數5
期刊Clinica Chimica Acta
404
發行號2
DOIs
出版狀態已發佈 - 六月 27 2009
對外發佈Yes

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

指紋 深入研究「Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia」主題。共同形成了獨特的指紋。

引用此